ROCC Knee Data Collection

Sponsor
Zimmer Biomet (Industry)
Overall Status
Terminated
CT.gov ID
NCT00758901
Collaborator
Biomet France SARL (Industry)
200
3
85
66.7
0.8

Study Details

Study Description

Brief Summary

This observational study intends to collect efficacy and safety data on ROCC Knee system.

Condition or Disease Intervention/Treatment Phase
  • Device: Knee Replacement (with ROCC Knee prosthesis)

Detailed Description

The ROCC® prosthesis is a rotating platform with:
  • Highly congruent surface contact,

  • NON CONSTRAINED kinematics allowing posterior roll back until 110° then anterior in hyperflexion like a normal knee

  • Allowing asymmetric movement

Study Design

Study Type:
Observational
Actual Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Prospective, Multicentre Study Evaluating the Clinical Performance of the ROCC Knee Prosthesis
Study Start Date :
Nov 1, 2003
Actual Primary Completion Date :
Dec 1, 2010
Actual Study Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
1 ROCC Knee prosthesis

Consecutive series of patients with ROCC Knee prosthesis.

Device: Knee Replacement (with ROCC Knee prosthesis)
Knee Replacement (with ROCC Knee prosthesis)
Other Names:
  • ROCC Knee prosthesis
  • Outcome Measures

    Primary Outcome Measures

    1. American Knee Score [3 months, 1yr, 2yr, 3yr, 4yr and 5 yr]

    Secondary Outcome Measures

    1. Complication [Any time]

    2. Patient Satisfaction [3 months, 1yr, 2yr, 3yr, 4yr and 5 yr]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Patients suitable for Knee Replacement for:
    • osteoarthritis,

    • rheumatoid arthritis

    • bone necrosis affecting two knee compartments,

    • correction of genu varus, genu valgus or post-traumatic deformities,

    • sequelae of prior procedures.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 A. ö Landeskrankenhaus Gmunden Gmunden Austria
    2 Clinique des Fontaines Meulin France
    3 Hospital Torrecardenas Almeria Spain

    Sponsors and Collaborators

    • Zimmer Biomet
    • Biomet France SARL

    Investigators

    • Principal Investigator: Michel BERCOVY, MD, Clinique des Fontaines

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zimmer Biomet
    ClinicalTrials.gov Identifier:
    NCT00758901
    Other Study ID Numbers:
    • BMET FR 03
    First Posted:
    Sep 25, 2008
    Last Update Posted:
    Mar 10, 2017
    Last Verified:
    Mar 1, 2017
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 10, 2017